Takeda Pharmaceutical TAK
NYSE TAK
$17.86 -0.01 (-0.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Return on Invested Capital [ROIC] (2019 - 2026)

Updated

Takeda Pharmaceutical's Return on Invested Capital [ROIC] was 4.36% in the quarter ended Jun 30, 2026, down 3.51 percentage points from 7.87% a year earlier but up 0.09 percentage points from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Return on Invested Capital [ROIC] (2019 - 2026) Analysis & Trends

For the year ended Mar 31, 2026, Return on Invested Capital [ROIC] at Takeda Pharmaceutical came in at 0.05%, down 2.84 percentage points from the prior year.

  • Return on Invested Capital [ROIC] shows a five-year change of -5.13 percentage points (years ended Mar 2021 to Mar 2026).
  • In earlier years, Return on Invested Capital [ROIC] was 2.89% in the year ended Mar 31, 2025 (+2.89 pp), 0.00% in the year ended Mar 31, 2024 (-4.33 pp), 4.33% in the year ended Mar 31, 2023 (-0.13 pp) and 4.46% in the year ended Mar 31, 2022 (-0.72 pp).
  • Quarterly Return on Invested Capital [ROIC] has moved between 4.27% (the quarter ended Mar 31, 2026) and 12.74% (the quarter ended Sep 30, 2022) over five years.
  • The best year-over-year quarter for Return on Invested Capital [ROIC] over five years was the quarter ended Mar 31, 2024 (a gain of 2.24 percentage points); the worst was the quarter ended Jun 30, 2023 (a drop of 5.16 percentage points).
  • Per Business Quant data, TAK's Return on Invested Capital [ROIC] in the three quarters before the quarter ended Jun 30, 2026 was 4.27% (quarter ended Mar 31, 2026), 5.22% (quarter ended Dec 31, 2025) and 9.84% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 Takeda Pharmaceutical 2.58 Bn -23.92 Bn 5.10 Bn 4.36%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.36%
Mar 31, 2026 4.27%
Dec 31, 2025 5.22%
Sep 30, 2025 9.84%
Jun 30, 2025 7.87%
Mar 31, 2025 7.45%
Jun 30, 2024 8.36%
Mar 31, 2024 9.02%
Dec 31, 2023 11.97%
Sep 30, 2023 12.18%
Jun 30, 2023 6.48%
Mar 31, 2023 6.78%
Dec 31, 2022 10.80%
Sep 30, 2022 12.74%
Jun 30, 2022 11.63%
Mar 31, 2022 11.57%
Jun 30, 2021 9.60%
Mar 31, 2021 9.97%
Dec 31, 2020 13.63%
Jun 30, 2020 7.93%
API Access

Takeda Pharmaceutical Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=TAK&period=max&api_key=YOUR_API_KEY